Right Rebate Act of 2018
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Dec 6, 2018)
Right Rebate Act of 2018
This bill requires drug manufacturers with Medicaid rebate agreements for covered outpatient drugs to disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly).
What just happenedDec 13, 2018
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseDec 6, 2018
- Dec 13, 2018Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Dec 6, 2018IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Dec 6, 2018IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Dec 6, 2018IntroReferralIntro-H
Introduced in House
- Dec 6, 2018IntroReferral1000
Introduced in House